Theranostics 2012; 2(3):313-317. doi:10.7150/thno.4007

Review

Clinical Indications of 11C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse

Maria Picchio1, Paolo Castellucci2✉

1. Nuclear Medicine Department, San Raffaele Scientific Institute, Milan, Italy; Institute for Bioimaging and Molecular Physiology, National Research Council (IBFM-CNR), Milan, Italy;
2. Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria di Bologna Policlinico S.Orsola-Malpighi, University of Bologna, Italy.

Abstract

Several studies investigated the potential role of imaging modalities in prostate cancer patients in case of biochemical recurrence. However, the role of molecular imaging has not been well established yet. Considering the results of the literature and of our own experience, we tried to summarize the potential applications of 11C-choline PET/CT in prostate cancer patients in case of biochemical relapse for the detection of lymph node and distant recurrence.

Keywords: prostate cancer, choline PET/CT, restaging.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Picchio M, Castellucci P. Clinical Indications of 11C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse. Theranostics 2012; 2(3):313-317. doi:10.7150/thno.4007. Available from http://www.thno.org/v02p0313.htm